Pharmacore secures funding to improve medication regimen reviews in long-term care Heavybit Raises $80M Fund From Dev Tools Unicorn Founders and LPs to Support the $900B Enterprise Software Boom
More than 20 founders of companies like Snyk, Sumo Logic, Fastly, LaunchDarkly, GitHub, and Datadog…
Digital Trends That Are Hard To Ignore
As the world moves further into the 21st century, technology becomes an increasingly integral part…
Broadcom Ships Trident 4C, Industry’s Highest Performance Security Switch
12.8 Tb/s Flow Anomaly Detection, No-Compromise Network Security, Connected by Broadcom SAN JOSE, Calif., Sept….
CohBar to Present at H.C. Wainwright 24th Annual Global Investment Conference
MENLO PARK, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical…
Iovance Biotherapeutics to Present Posters at ESMO 2022
SAN CARLOS, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a…
Ocuphire Pharma to Present at The H.C. Wainwright 24th Annual Global Investment Conference
FARMINGTON HILLS, Mich., Sept. 06, 2022 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a…
Tilray Initiates Roundtable With German Regulators to Kick-Off Draft Legislation to Legalize Adult-Use Cannabis in Germany
BERLIN, Sept. 06, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq:…
Reneo Pharmaceuticals to Participate at Upcoming Investor Conferences
IRVINE, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical…
Vericel to Present at the Morgan Stanley Global Healthcare and H.C. Wainwright Global Investment Conferences
CAMBRIDGE, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced…
Galecto to Participate at H.C. Wainwright 24th Annual Global Investment Conference
BOSTON, Sept. 06, 2022 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology…
Veru to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 12th, 2022
MIAMI, Sept. 06, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused…
Agile Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
PRINCETON, N.J., Sept. 06, 2022 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare…
BioCorRx to Present at the H.C. Wainwright 24th Annual Global Investment Conference
ANAHEIM, CA, Sept. 06, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – BioCorRx Inc. (OTCQB: BICX)…
eFFECTOR Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference
SAN DIEGO and REDWOOD CITY, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics, Inc….
Reviva Pharmaceuticals Holdings, Inc. Announces $8.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
CUPERTINO, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva”…
Longeveron to Present at H.C. Wainwright 24th Annual Global Investment Conference
MIAMI, Sept. 06, 2022 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a…
Spero Therapeutics Provides Tebipenem HBr Program Update Following Type A Meeting with the U.S. Food and Drug Administration
Alignment with the FDA on a regulatory path forward for the continued development of tebipenem…
CymaBay Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
NEWARK, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage…
Satsuma Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
South San Francisco, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA),…
SeqLL to Present at the H.C. Wainwright 24th Annual Global Conference
BILLERICA, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:…